Liuliang Qin Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School , 99 Brookline Avenue RN 270A, Boston, MA 02215, USA Mol Cancer Res 4:811-20.
DSCR1-1L, unlike DSCR1-4, potently activates angiogenesis and could be an attractive target for antiangiogenesis therapy....